| CXSB2300100 | 重组红细胞生成刺激蛋白注射液（CHO细胞） | | Injection | Biological Products(原9) | Supplementary Application | 2023-09-19 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2500031 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(1) | Supplementary Application | 2025-01-27 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CSB00025 | 重组人红细胞生成素注射液 | Human Erythropoietin | Injection | Biological Products(2) | Supplementary Application | 2000-10-18 | 沈阳三生制药股份有限公司 | Shenyang Sunshine Pharmaceutical Co Ltd | In Approval | | view |
| CXSB0890001 | 重组人红细胞生成素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2008-10-07 | 沈阳三生制药股份有限公司 | Shenyang Sunshine Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | | view |
| CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXHL2500177 | HIF-117胶囊 | HIF-117 | Capsule | Chemical Drugs(1) | New Drug Application | 2025-02-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSS2200089 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(2.2) | New Drug Application | 2022-11-02 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400178 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200217 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400261 | 注射用人干扰素α2a | recombinant human interferon α2a | Lyophilized | Biological Products | Supplementary Application | 2024-09-27 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL2500310 | SSS55注射液 | SSS-55 | Injection | Biological Products(1) | New Drug Application | 2025-04-17 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2500032 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(1) | Supplementary Application | 2025-01-27 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2300022 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products | Supplementary Application | 2023-01-30 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXHL2500178 | HIF-117胶囊 | HIF-117 | Capsule | Chemical Drugs(1) | New Drug Application | 2025-02-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400177 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200267 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSS2400090 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(2.2) | New Drug Application | 2024-08-30 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL2500269 | 注射用SSGJ-612 | SSGJ-612 | Lyophilized | Biological Products(1) | New Drug Application | 2025-04-07 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL2500006 | 注射用SSS59 | | | Biological Products(1) | New Drug Application | 2025-01-03 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
